Copyright
©The Author(s) 2024.
World J Clin Oncol. Apr 24, 2024; 15(4): 540-547
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.540
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.540
Table 2 Comparative analysis of survival outcomes
| Survival analysis | Microsatellite instability-high | Microsatellite stable | ||
| Immunotherapy vs chemotherapy | Hazard ratio (95%CI) | Adjusted hazard ratio (95%CI) | Hazard ratio (95%CI) | Adjusted hazard ratio (95%CI) |
| Overall | 0.75 (0.57-0.99) | 0.57 (0.43-0.77) | 1.05 (0.77-1.43) | 0.94 (0.69-1.29) |
| One year | 1.32 (0.92-1.92) | 1.23 (0.84-1.81) | 1.43 (0.95-2.14) | 1.37 (0.91-2.06) |
| Three year | 0.74 (0.56-0.98) | 0.62 (0.46-0.82) | 0.98 (0.72-1.34) | 0.88 (0.65-1.21) |
- Citation: Niu CG, Zhang J, Rao AV, Joshi U, Okolo P. Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status. World J Clin Oncol 2024; 15(4): 540-547
- URL: https://www.wjgnet.com/2218-4333/full/v15/i4/540.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i4.540